OpenAlex
PricingAboutJobs
Log inGet started
Work

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)

HTML

Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2004-08-3231
Authors: Giovanni Palladini, Vittorio Perfetti, Stefano Perlini, Laura Obici, Francesca Lavatelli, Riccardo Caccialanza, Rosangela Invernizzi, Benedetto Comotti, Giampaolo Merlini
Institutions: University of Pavia, Humanitas Gavazzeni, Policlinico San Matteo Fondazione
Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Subfield: Internal Medicine
Field: Medicine
Domain: Health Sciences
Keywords: thalidomide, dexamethasone, AL amyloidosis, combination chemotherapy, second-line therapy, relapsed/refractory disease, hematologic response, organ response, bradycardia, treatment toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2041167176
FWCI: 16.78
Cites: 25
Cited by: 237
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms